HomeTPST • NASDAQ
add
Tempest Therapeutics Inc
Previous close
$9.12
Day range
$9.15 - $10.01
Year range
$5.35 - $15.08
Market cap
44.45M USD
Avg Volume
41.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.97M | -16.86% |
Net income | -7.87M | 17.76% |
Net profit margin | — | — |
Earnings per share | -2.07 | 62.09% |
EBITDA | -7.90M | 16.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.28M | -54.12% |
Total assets | 24.48M | -41.94% |
Total liabilities | 14.70M | -41.73% |
Total equity | 9.78M | — |
Shares outstanding | 4.44M | — |
Price to book | 4.15 | — |
Return on assets | -70.31% | — |
Return on capital | -93.31% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -7.87M | 17.76% |
Cash from operations | -8.43M | -53.01% |
Cash from investing | — | — |
Cash from financing | 1.20M | -73.67% |
Net change in cash | -7.23M | -501.58% |
Free cash flow | -5.64M | -112.88% |
About
Founded
2011
Headquarters
Website
Employees
21
